Ligand profile
SZP
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_04549 — NAD-dependent malic enzyme
Identifiers
Database identifiers and provenance.
- Ligand ID
SZP- PDB
6w53- UniProt (similar protein)
Q4DJ68- Target protein
- KP13_04549
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 84.5
- −1 ≤ LogP ≤ 5 5.57
- MW ≤ 500 Da 506.8
- LogP ≤ 5 5.57
- H-bond donors ≤ 5 2
- H-bond acceptors ≤ 10 4
- Rotatable bonds ≤ 10 6
- TPSA ≤ 140 Ų 84.5
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
c1cc(ccc1NS(=O)(=O)c2ccc(c(c2)NC(=O)c3cc(cc(c3)F)F)Cl)OC(F)(F)Fc1cc(ccc1NS(=O)(=O)c2ccc(c(c2)NC(=O)c3cc(cc(c3)F)F)Cl)OC(F)(F)F
InChI=1S/C20H12ClF5N2O4S/c21-17-6-5-16(10-18(17)27-19(29)11-7-12(22)9-13(23)8-11)33(30,31)28-14-1-3-15(4-2-14)32-20(24,25)26/h1-10,28H,(H,27,29)InChI=1S/C20H12ClF5N2O4S/c21-17-6-5-16(10-18(17)27-19(29)11-7-12(22)9-13(23)8-11)33(30,31)28-14-1-3-15(4-2-14)32-20(24,25)26/h1-10,28H,(H,27,29)
HMZYFFHZWUTOLH-UHFFFAOYSA-NHMZYFFHZWUTOLH-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00390
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand SZP →
- PDB RCSB structure 6w53 →
- UniProt UniProt Q4DJ68 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “SZP”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_04549.
PDB 12
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 2
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).